We are looking for 2–17 years of age to join a Crohn’s disease (CD) clinical research study to help us discover more about treating moderate to severe ulcerative colitis. If you are looking for a potential new treatment option for moderate to severe ulcerative colitis or moderate to severe ulcerative colitis (including associated symptoms such as painful joints, fatigue, cramps, weight loss and/or canker sores), consider one of our CD and UC studies. All eligible participants will receive no-cost study-related care and study medication. Your 2–17 years of age may be eligible to take part.
Your child may be eligible to take part in the CD and UC studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
See if your child qualifies.
